Xtant Medical Holdings
XTNT
18 hedge funds and large institutions have $5.4M invested in Xtant Medical Holdings in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
4% more capital invested
Capital invested by funds: $5.21M → $5.4M (+$190K)
0% more funds holding
Funds holding: 18 → 18 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Goldman Capital Management
New York
|
+$257K |
| 2 |
Millennium Management
New York
|
+$59.1K |
| 3 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$23.9K |
| 4 |
Morgan Stanley
New York
|
+$14.4K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$7.99K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
Bard Associates
Chicago,
Illinois
|
-$7.73K |
| 2 |
GI
Gradient Investments
Arden Hills,
Minnesota
|
-$3K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$1.53K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$351 |
XTNT Hedge Fund Activity: Q1 2016 in Review
18 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q1 2016, worth a combined $5.4M — up 3.6% from $5.21M a quarter earlier.
Fund positioning in XTNT was balanced in Q1 2016: 2 funds opened new positions, 2 closed out, 5 added to existing stakes and 3 trimmed.
The largest buyer was Goldman Capital Management, adding an estimated $257K. The largest seller was Bard Associates, cutting an estimated $7.73K.
- 18 institutional investors held Xtant Medical Holdings (XTNT) as of Q1 2016, unchanged from Q4 2015.
- Funds reported $5.4M of Xtant Medical Holdings stock for Q1 2016, up 3.6% quarter-over-quarter.
- 2 funds opened new Xtant Medical Holdings positions in Q1 2016 and 2 closed out, a net change of 0 holders.
- The largest Xtant Medical Holdings buyer in Q1 2016 was Goldman Capital Management, an estimated $257K added.
- The largest Xtant Medical Holdings seller in Q1 2016 was Bard Associates, an estimated $7.73K sold.
Based on aggregated 13F filings for Q1 2016.